DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway

Zheng Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yuan Lin(Sun Yat-sen University)
Oncology Letters
December 28, 2018
Cited by 8


Related Papers